| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 01/19/2011 | CN101502496B Method for preparing norfloxacin capsule |
| 01/19/2011 | CN101485626B Aqueous solution containing coenzyme Q10 nano granule and preparation method thereof |
| 01/19/2011 | CN101463092B Preparation of rapid disintegrating agent carboxymethyl-crosslinked starch sodium |
| 01/19/2011 | CN101422549B Traditional Chinese medicine external preparation capable of improving ascites due to cirrhosis and preparation method thereof |
| 01/19/2011 | CN101375849B Novel dosage form of sinomenine medicament or hydrochlorate thereof and preparation technique thereof |
| 01/19/2011 | CN101361979B Solid preparation film coating agent and preparation method thereof |
| 01/19/2011 | CN101361742B Aminophylline oral solution and preparation method thereof |
| 01/19/2011 | CN101322681B Method for preparing nano micelle formulation of anthracene nucleus antineoplastic antibiotic |
| 01/19/2011 | CN101304730B Topical formulations |
| 01/19/2011 | CN101237885B Agent for regeneration and/or protection of nerves |
| 01/19/2011 | CN101234205B High molecule adriamycin bonding medicine nano capsule with targeting function and preparation thereof |
| 01/19/2011 | CN101184489B Pharmaceutical composition |
| 01/19/2011 | CN101156952B DC cell targeted carrier, nanometer corpuscle and preparation method |
| 01/19/2011 | CN101119716B External plaster containing flurbiprofen |
| 01/19/2011 | CN101103967B Medicine composition containing bevantolol hydrochloride |
| 01/19/2011 | CN101091695B Pharmaceutical formulation |
| 01/19/2011 | CN101088505B Nanometer breviscapine polymer particle preparation and its preparation process |
| 01/19/2011 | CN101019851B Medium chain fatty acid liposome and its preparation |
| 01/19/2011 | CN101011419B Propolis preparation and its preparation method |
| 01/18/2011 | US7872105 single domain antibody AFAI; binds to non-small cell lung carcinoma; kits |
| 01/18/2011 | US7872072 Branched water soluble polymers containing at least two arms, such as polyoxyethylene glycol, linked to a central aliphatic hydrocarbon core molecule through heteroatom linkage and one functional group for reacting biological active agent; drugs/polymer conjugates/;bioavailability |
| 01/18/2011 | US7871968 Medicinal soap comprising sapropel |
| 01/18/2011 | US7871818 Membrane active polymers |
| 01/18/2011 | US7871765 Composition having antitumor effect |
| 01/18/2011 | US7871644 Mixture of drug, aminoacrylate polymer and acid |
| 01/18/2011 | US7871631 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/18/2011 | US7871620 Immunoliposomes that optimize internationalization into target cells |
| 01/18/2011 | US7871608 Reversibly inactivated acidified plasmin |
| 01/18/2011 | US7871598 exhibit improved stability and dispersability over the shelf life of the composition; microparticles are simple to produce without the need of the formation of an emulsion or the use of an oil as a blowing agent |
| 01/18/2011 | US7871597 Administering parenterally effective dose of iron oxide complex with polyol or polyether formulated in biocompatible liquid so that upon administration provides minimal detectable free iron in and minimal incidence of anaphylaxis |
| 01/18/2011 | CA2637795C Antagonists of interleukin-15 |
| 01/18/2011 | CA2576549C Stable pegylated interferon formulation |
| 01/18/2011 | CA2519408C High concentration antibody and protein formulations |
| 01/18/2011 | CA2503274C Basic medicine-containing preparation |
| 01/18/2011 | CA2477773C A stable diclofenac-tromethamine composition for the topical treatment of oropharyngeal cavity disorders |
| 01/18/2011 | CA2477769C Ophthalmic composition comprising ascomycin |
| 01/18/2011 | CA2466642C Injectable depot composition |
| 01/18/2011 | CA2452386C Granulates containing liposoluble substances and a process for the preparation thereof |
| 01/18/2011 | CA2441964C New pharmaceutical compositions based on anticholinergics and endothelin antagonists |
| 01/18/2011 | CA2420130C Composition for aqueous stabilization of fat-soluble vitamins |
| 01/18/2011 | CA2408008C Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin |
| 01/18/2011 | CA2407290C Compound comprising crosslinked polyrotaxane |
| 01/18/2011 | CA2401089C Anaesthetic formulations |
| 01/18/2011 | CA2400666C Method for preparing functionalised polyalkylenimines, composition containing same and uses thereof |
| 01/18/2011 | CA2368637C Topical treatment or prevention of ocular infections |
| 01/18/2011 | CA2338665C Peg-urate oxidase conjugates and use thereof |
| 01/18/2011 | CA2189055C Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 01/13/2011 | WO2011006029A1 Artificial cell constructs for inducing immunological tolerance |
| 01/13/2011 | WO2011005853A2 Compositions and methods of topical drug delivery for the treatment of carpal tunnel syndrome |
| 01/13/2011 | WO2011005850A1 Lipidic compositions for induction of immune tolerance |
| 01/13/2011 | WO2011005756A1 Delivery of agents targeted to microbiota niches |
| 01/13/2011 | WO2011005540A1 Methods and compositions using peptides and proteins with c-terminal elements |
| 01/13/2011 | WO2011005270A1 Peracid/peroxide composition, process for accurately making the same, and method for use as an evaporating film anti-microbial solution and as a photosensitizer |
| 01/13/2011 | WO2011005113A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 01/13/2011 | WO2011005098A1 Peptide ligands for targeting to the blood-brain barrier |
| 01/13/2011 | WO2011004799A1 Tablet having hollow structure |
| 01/13/2011 | WO2011004552A1 Water-soluble drug carrier and process for production thereof |
| 01/13/2011 | WO2011004395A1 Microemulsion formulation for biologicals |
| 01/13/2011 | WO2011004379A1 Compositions and methods for treating cancer |
| 01/13/2011 | WO2011004293A1 Method for preparing polymerized lipid constructs, resulting polymerized lipid constructs, and uses thereof for encapsulating active agents |
| 01/13/2011 | WO2011004117A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
| 01/13/2011 | WO2011004010A1 Solid linear oligo-or poly-e-caprolactone derivatives |
| 01/13/2011 | WO2011003886A1 Pegylated l-asparaginase |
| 01/13/2011 | WO2011003780A1 Bi-specific digoxigenin binding antibodies |
| 01/13/2011 | WO2011003766A1 Biodegradable copolymer comprising amylopectin or glycogen suitable for delivering nucleic acid materials into cells |
| 01/13/2011 | WO2011003633A1 Pegylated l-asparaginase |
| 01/13/2011 | WO2011003622A1 Method for the production of variable domains |
| 01/13/2011 | WO2011003557A1 A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent |
| 01/13/2011 | WO2011003430A1 Liquid pharmaceutical form of alkylphosphocholine and method of preparing same |
| 01/13/2011 | WO2011003240A1 Formulation comprising terpolymer and active substance, and preparation thereof |
| 01/13/2011 | WO2011003172A1 Controlled nitric oxide delivery from aqueous s-nitrosothiol conjugated polymers and their complexes |
| 01/13/2011 | WO2011003155A1 Biopolymer hybrid gel-depot delivery system |
| 01/13/2011 | WO2010133941A3 New hybrid particles and their use in diagnostics and therapy |
| 01/13/2011 | WO2010132047A8 Guanosine/gmp gels and uses thereof |
| 01/13/2011 | WO2010120389A3 Polymeric drug delivery systems and processes for producing such systems |
| 01/13/2011 | WO2010099542A3 Formulations of atp and analogas of atp |
| 01/13/2011 | WO2010094720A3 Improved anti-tnfr1 polypeptides, antibody variable domains & antagonists |
| 01/13/2011 | WO2010081824A3 Active coating of pharmaceutical dosage forms |
| 01/13/2011 | WO2010079052A3 Nanoparticle compositions |
| 01/13/2011 | WO2010017328A3 Cyclodextrin conjugates for sirna delivery |
| 01/13/2011 | WO2010003268A3 Methods and compositions for enhanced delivery of macromolecules |
| 01/13/2011 | WO2009099831A3 Edible film-strips with modified release active ingredients |
| 01/13/2011 | WO2009061482A3 Anesthetic composition, formulation and method of use |
| 01/13/2011 | US20110009589 Degradable heterobifunctional poly(ethylene glycol) acrylates and gels and conjugates derived therefrom |
| 01/13/2011 | US20110009497 Drug-containing composition |
| 01/13/2011 | US20110009481 Medicament for the treatment of viral skin and tumour diseases |
| 01/13/2011 | US20110009333 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 01/13/2011 | US20110009321 Nasal calcitonin formulations containing chlorobutanol |
| 01/13/2011 | US20110008543 Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/13/2011 | US20110008444 Composition for the formation of gels |
| 01/13/2011 | US20110008435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic Compounds |
| 01/13/2011 | US20110008424 Sustained Release Solid Formulations and Methods of Manufacturing the Same |
| 01/13/2011 | US20110008415 Novel lipophilic compositions and uses thereof |
| 01/13/2011 | US20110008404 Modification Of Biomaterials With Microgel Films |
| 01/13/2011 | US20110008373 Prodrugs of cc-1065 analogs |
| 01/13/2011 | US20110008338 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008337 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008336 Treatment of Autoimmune Diseases |
| 01/13/2011 | US20110008304 Use of cells to facilitate targeted delivery of nanoparticle therapies |
| 01/13/2011 | US20110008266 Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |